Histone deacetylase inhibitors decrease proliferation potential and multilineage differentiation capability of human mesenchymal stem cells.
OBJECTIVE
Histone deacetylase (HDAC) is an important therapeutic target in cancer. Two of the main anticancer mechanisms of HDAC inhibitors are induction of terminal differentiation and inhibition of cell proliferation. To investigate the role of HDAC in maintenance of self-renewal and cell proliferation, we treated mesenchymal stem cells (MSCs) that originated from adipose tissue or umbilical cord blood with valproic acid (VPA) and sodium butyrate (NaBu).


METHODS
Human MSCs were isolated from mammary fat tissue and cord blood. We performed MTT assay and flow cytometry-based cell cycle analysis to assess self-renewal of MSCs. In vitro differentiation assays into osteogenic, adipogenic, neurogenic and chondrogenic lineages were conducted to investigate MSC multipotency. Immunocytochemistry, Western blot and reverse transcription-polymerase chain reaction were used to interrogate molecular pathways.


RESULTS
VPA and NaBu flattened the morphology of MSCs and inhibited their growth. VPA and NaBu activated the transcription of p21(CIP1/WAF1) by increasing the acetylation of histone H3 and H4 and eventually blocked the cell cycle at G2/M phase. The expression level of p16(INK4A), a cdk inhibitor that is closely related to cellular senescence, was not changed by HDAC inhibitor treatment. We performed controlled differentiation into bone, fat, cartilage and nervous tissue to elucidate the role of HDAC in the pluripotency of MSC to differentiate into functional tissues. VPA and NaBu decreased the efficiency of adipogenic, chondrogenic, and neurogenic differentiation as visualized by specific staining and reverse transcription-polymerase chain reaction. In contrast, osteogenic differentiation was elevated by HDAC inhibitor treatment.


CONCLUSIONS
HDAC activity is essential for maintaining the self-renewal and pluripotency of MSCs.
Lee
S
S
Adult Stem Cell Research Center, Seoul National University, Seoul, South Korea.
Park
J-R
JR
Seo
M-S
MS
Roh
K-H
KH
Park
S-B
SB
Hwang
J-W
JW
Sun
B
B
Seo
K
K
Lee
Y-S
YS
Kang
S-K
SK
Jung
J-W
JW
Kang
K-S
KS
D015153:Blotting, Western; D002453:Cell Cycle / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects*; D019070:Cell Lineage; D049109:Cell Proliferation / Q000187:drug effects*; D050759:Cyclin-Dependent Kinase Inhibitor p21 / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D056572:Histone Deacetylase Inhibitors; D006801:Humans; D007150:Immunohistochemistry; D059630:Mesenchymal Stem Cells / Q000166:cytology / Q000187:drug effects*; D010012:Osteogenesis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015854:Up-Regulation
C493956:CDKN1A protein, human; D050759:Cyclin-Dependent Kinase Inhibitor p21; D004791:Enzyme Inhibitors; D056572:Histone Deacetylase Inhibitors
Biochem Biophys Res Commun. 2008 Jan 4;365(1):124-30
17980151
Cell Death Differ. 2005 Jan;12(1):65-77
15459751
Biochem Biophys Res Commun. 2007 May 4;356(2):386-91
17368572
J Clin Invest. 2004 Jan;113(2):160-8
14722605
PLoS One. 2008 May 21;3(5):e2213
18493317
Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10014-9
10954755
Nat Rev Cancer. 2006 Nov;6(11):846-56
17060944
Genes Dev. 2007 Mar 1;21(5):525-30
17344414
J Biol Chem. 2001 Nov 9;276(45):42084-90
11551946
J Biol Chem. 2001 Nov 2;276(44):40778-87
11524416
J Biol Chem. 2004 Apr 30;279(18):18851-60
14985358
Biochem Pharmacol. 2007 May 1;73(9):1297-307
17276411
FASEB J. 2006 Jul;20(9):1516-8
16754749
J Cell Biochem. 2005 Oct 15;96(3):533-42
16088945
Stem Cells. 2006 May;24(5):1294-301
16410387
Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13742-7
8943005
Biochem Biophys Res Commun. 2007 Apr 20;355(4):913-8
17331472
Cancer. 2007 Sep 1;110(5):943-54
17647267
Biochem Biophys Res Commun. 2007 Mar 23;354(4):919-23
17274951
Cancer Lett. 2005 Jul 28;225(2):199-206
15978324
Haematologica. 2007 Apr;92(4):542-5
17488665
BMC Cell Biol. 2006 Mar 10;7:14
16529651
J Biol Chem. 2006 Mar 10;281(10):6608-15
16407282
Cancer Lett. 2005 Dec 18;230(2):239-47
16297710
Genome Biol. 2008 Apr 04;9(4):R65
18394158
Cell Prolif. 2008 Dec;41(6):859-874
19040566
J Cell Biochem. 2004 Sep 1;93(1):57-67
15352162
Stem Cell Rev. 2007 Dec;3(4):239-48
18074246